血管介入后非索引医院再入院与死亡率显著升高相关
基于2013至2014年美国全国再入院数据库,纳入92,769例因跛行或严重肢体缺血行血管介入的患者,分析30天和365天再入院率及非索引医院再入院对死亡率的影响。结果显示非索引医院再入院占再入院的20.47%和24.92%,且与显著更高的死亡率相关。
要点
- 跛行和严重肢体缺血患者30天再入院率分别为8.97%和19.26%,365天分别为21.49%和40.36%。
- 30天和365天再入院中分别有20.47%和24.92%发生在非索引医院。
- 非索引医院再入院与30天和365天死亡率升高相关(OR分别为1.4和1.8)。
核心结论
- 因外周血管疾病行下肢血管手术后的再入院中,至少四分之一发生在非索引医院。
- 这种医疗碎片化与死亡率升高相关,并对结局和质量指标有严重启示。
研究设计与样本
- 回顾性队列研究,查询2013至2014年美国全国再入院数据库。
- 纳入因跛行或严重肢体缺血行血管成形术、下肢旁路术或主双股旁路术的患者,共92,769例(跛行33,055例,严重肢体缺血59,714例)。
主要发现
- 跛行患者30天和365天再入院率分别为8.97%和21.49%,严重肢体缺血患者分别为19.26%和40.36%。
- 30天和365天再入院中非索引医院再入院分别占20.47%和24.92%。
- 非索引医院30天或365天再入院患者死亡率显著更高(OR分别为1.4和1.8)。
- 女性、住院时间>7天和Charlson合并症指数>3是非索引医院再入院的显著危险因素。
- 非索引医院再入院最常见疾病组为败血症和播散性感染(6.5%)、心力衰竭(6.4%)、其他血管手术(6.1%)和除趾外的下肢截肢(4.0%)。
临床怎么用
- 临床应关注血管介入术后再入院,尤其是非索引医院再入院,因其与死亡率升高相关。
- 针对女性、住院时间>7天和Charlson合并症指数>3的高危患者,可能需加强出院后管理。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hospital readmissions with 30 days after vascular surgical interventions have been associated with increased morbidity, mortality, and cost. Readmission rates, now a Centers for Medicare and Medicaid Services quality measure, have been studied in databases that have excluded certain payer types and states and have not accounted for readmission to a hospital different from that of the index admission. More accurate and nationally representative data are needed, because this fragmentation of care could lead to flawed conclusions. The purpose of the present study was to examine the incidence and risk factors for readmission to a nonindex hospital for patients admitted for claudication or critical limb ischemia (CLI). We also examined how this disruption of patient care affects mortality. METHODS: The 2013 to 2014 Nationwide Readmissions Database was queried for all patients admitted for claudication or CLI who had undergone angioplasty, lower extremity bypass, or aortobifemoral bypass. The outcomes of interest were 30- and 365-day readmission rates to any hospital, 30- and 365-day readmission rates to a nonindex hospital, and mortality rates. Multivariable logistic regression was used to identify risk factors for readmission to a nonindex hospital. The most common readmission diagnoses and diagnosis-related groups were identified. RESULTS: A total of 92,769 patients had been admitted with peripheral vascular disease (33,055 with claudication and 59,714 with CLI). The 30- and 365-day readmission rate was 8.97% and 21.49% and 19.26% and 40.36%, for claudication and CLI, respectively. Of the 30- and 365-day readmissions, 20.47% and 24.92% had occurred at a nonindex hospital, respectively. Significantly higher mortality rates were found for patients with 30- or 365-day readmissions to different hospitals (odds ratio, 1.4 and 1.8, respectively). Multivariable analysis revealed that procedural indication and angioplasty are not significant risk factors for readmission to a different hospital. However, female sex, length of stay >7 days, and Charlson Comorbidity Index >3 remained significant risk factors for nonindex readmissions. The most common disease groups for nonindex readmission were "septicemia and disseminated infections" (6.5%), "heart failure" (6.4%), "other vascular procedures" (6.1%), and "amputation of lower limb except toes" (4.0%). CONCLUSIONS: Previously unreported, ≥1 in 4 readmissions after lower extremity vascular procedures for peripheral vascular disease will occur at a nonindex hospital. This fragmentation of care is associated with increased mortality and has serious implications for guiding outcome and quality measures. With a sizeable portion of patients missed by current metrics, concern exists that providers are using flawed data. Further study into social- and patient-specific risk factors might provide methods to prevent these readmissions and improve outcomes in this difficult patient population.
引用
- Martinez RA, Franklin KN, Hernandez AE, et al. Readmissions to an alternate hospital in patients undergoing vascular intervention for claudication and critical limb ischemia associated with significantly higher mortality. J Vasc Surg. 2019. PMID: 31153697. doi:10.1016/j.jvs.2019.02.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。